Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DATOPOTAMAB DERUXTECAN-DLNK vs DECITABINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DATOPOTAMAB DERUXTECAN-DLNK vs DECITABINE: Safety Overview

Metric DATOPOTAMAB DERUXTECAN-DLNK DECITABINE
Total FAERS Reports 165 2,983
Deaths Reported 36 816
Death Rate 21.8% 27.4%
Hospitalizations 33 1,060
Average Patient Age 61.4 yrs 56.2 yrs
% Female Patients 89.2% 43.2%
FDA Approval Date N/A Apr 12, 2021
Manufacturer N/A Qilu Pharmaceutical Co., Ltd.
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued